B2M and neoplasm: In the presence of B2M/beta 2 microglobulin, immunogen-presenting cells show predominantly viral and tumor-derived peptides for identification by the alpha-beta T cell receptor (TCR) on HLA-A-restricted CD8-positive T cells.